Q & A

Read the latest PLC CEO interviews. CEO’s from UK listed PLC’s, Analysts and Fund Managers answering questions about their business.

Manx Financial CEO Douglas Grant discusses Q3 progress and growth strategy

Manx Financial Group CEO Douglas Grant speaks to DirectorsTalk about third-quarter financial performance, new lending products, structured finance growth, Payment Assist expansion, business consolidation and AI..

Gattaca CEO Matthew Wragg discusses 85% profit growth and FY27 outlook

Gattaca Chief Executive Officer Matthew Wragg speaks to DirectorsTalk about the Group's 11% net fee income growth, 85% increase in profit before tax, sector performance, strategic..

ICG Enterprise Trust: Investment strategy, Portfolio performance and Outlook (LON:ICGT)

Hardman & Co Analyst Mark Thomas discusses ICG Enterprise Trust’s first-half FY27 results, portfolio growth, private equity investment strategy, exit opportunities, AI exposure and shareholder returns...

Ilika CEO Graeme Purdy on ORKA brand launch and deep-sea battery demand

Ilika CEO Graeme Purdy discusses the launch of the ORKA brand for marine applications, the commercial potential of its Goliath solid-state battery technology, and opportunities to..

Neuberger Private Equity Partners: Stronger realisations and shareholder returns

Hardman & Co analyst Mark Thomas discusses Neuberger Private Equity Partners Limited (LON:NBPE), highlighting 12% portfolio company EBITDA growth, expected realisations of at least 18% of..

accesso CEO Lee Cowie on AI, payments and near-doubling of multi-product opportunities

accesso Technology Group plc (LON:ACSO) CEO Lee Cowie discusses the company's AI strategy, integrated payments through Adyen and software ecosystem, highlighting a near-doubling of multi-product sales..

Meridian Holdings CFO William Scott on profitability, debt reduction and growth priorities

Chairman and CFO William Scott discusses Meridian Holdings’ improving financial performance, gaming technology, debt reduction, Brazil exposure and strategic priorities for the next 12 months...

Physitrack CEO Henrik Molin outlines EMR Launch, AI strategy and 2027 growth plans

Physitrack CEO Henrik Molin discusses 14% year-on-year revenue growth, early sign-ups for its new electronic medical record system, remote therapeutic monitoring and plans to expand its..

Genflow Biosciences CEO Dr Eric Leire discusses SIRT6 gene therapy results in aged dogs

Genflow Biosciences CEO Dr Eric Leire discusses interim SLAB-VET trial results, the potential of SIRT6 gene therapy in ageing dogs, plasmid DNA delivery, veterinary licensing opportunities..

Oriole Resources’ Martin Rosser outlines Wapouzé development plans (LON:ORR)

Oriole Resources plc CEO Martin Rosser discusses the maiden 32.2 million tonne resource at Wapouzé in Cameroon, the potential for a multi-decade quarrying operation and plans..

Hercules CEO Brusk Korkmaz outlines £5m contract wins and £50m growth target

Hercules plc CEO Brusk Korkmaz discusses £5 million of new civil project contracts, opportunities arising from the UK water sector’s £104 billion AMP8 investment programme and..

Avingtrans CEO Steve McQuillan on record revenue, nuclear demand and medical imaging progress

Avingtrans plc (LON: AVG) CEO Steve McQuillan discusses record revenue of £163 million, adjusted EBITDA exceeding £20 million, a strong order book and growing demand for..

Finsbury Growth & Income Trust: Nick Train on AI, Brands and UK Valuations

Finsbury Growth & Income Trust portfolio manager Nick Train discusses the trust’s long-term investment approach, AI and data businesses, consumer brands, recent holdings including TP ICAP..

Manx Financial CEO Douglas Grant on record £422.9m loan book and Payment Assist growth

Manx Financial Group CEO Douglas Grant discusses the Group’s first-half 2026 performance, record loan book, Payment Assist growth, Triskel Finance, AI and automation, and plans to..

Chesnara reports early acquisition synergies as M&A pipeline remains strong (LON:CSN)

Chesnara says recent acquisitions have delivered £51 million of structural day one synergies, with further benefits expected from migration, integration and capital management. The group also..

CMC Markets – A catch up with Lord Peter Cruddas

CMC Markets CEO Lord Peter Cruddas said the group is accelerating its expansion across B2B and institutional markets, with more than 300 global partnerships and agreements..

Biotech Growth Trust Portfolio Manager on valuations, M&A and sector recovery

Biotech Growth Trust Co-Portfolio Manager Josh Golomb discusses the long-term investment opportunity in biotechnology, BIOG’s recent performance, recovering valuations, pharmaceutical M&A activity and developments in cancer..

CMC Markets MD Chris Cheverall on 24/7 market access, CMC Connect and AI opportunities

CMC Markets MD Chris Cheverall discusses rising demand for 24/7 market access, the expansion of CMC Connect, API technology and how AI could create new distribution..

Premier Miton UK Multi Cap Income Fund: The case for UK income and small-cap stocks

Gervais Williams outlines his views on UK equities, income growth and the potential for a shift towards lower-beta, income-generating shares...

Personal Group praised by Fund Manager for income growth and market share gains

Premier Miton’s Gervais Williams discusses Personal Group Holdings’ 22% rise in adjusted EBITDA, record insurance sales, improving market share and prospective dividend yield of around 6%...
Search

Funds

Q & A

Manx Financial CEO Douglas Grant discusses Q3 progress and growth strategy

Manx Financial Group CEO Douglas Grant speaks to DirectorsTalk about third-quarter financial performance, new lending products, structured finance growth, Payment Assist expansion, business consolidation and AI developments, outlining the Group's priorities for 2027 and beyond...

Gattaca CEO Matthew Wragg discusses 85% profit growth and FY27 outlook

Gattaca Chief Executive Officer Matthew Wragg speaks to DirectorsTalk about the Group's 11% net fee income growth, 85% increase in profit before tax, sector performance, strategic priorities and outlook for FY27, highlighting continued progress and opportunities for further growth...

ICG Enterprise Trust: Investment strategy, Portfolio performance and Outlook (LON:ICGT)

Hardman & Co Analyst Mark Thomas discusses ICG Enterprise Trust’s first-half FY27 results, portfolio growth, private equity investment strategy, exit opportunities, AI exposure and shareholder returns...

Ilika CEO Graeme Purdy on ORKA brand launch and deep-sea battery demand

Ilika CEO Graeme Purdy discusses the launch of the ORKA brand for marine applications, the commercial potential of its Goliath solid-state battery technology, and opportunities to supply integrated battery solutions for autonomous underwater vehicles used to monitor subsea infrastructure and protect critical assets in areas such as the Arctic...

Neuberger Private Equity Partners: Stronger realisations and shareholder returns

Hardman & Co analyst Mark Thomas discusses Neuberger Private Equity Partners Limited (LON:NBPE), highlighting 12% portfolio company EBITDA growth, expected realisations of at least 18% of opening NAV in 2026, increased investment activity and a dividend yield approaching 5%...

accesso CEO Lee Cowie on AI, payments and near-doubling of multi-product opportunities

accesso Technology Group plc (LON:ACSO) CEO Lee Cowie discusses the company's AI strategy, integrated payments through Adyen and software ecosystem, highlighting a near-doubling of multi-product sales opportunities and potential cost savings for venue operators...

Meridian Holdings CFO William Scott on profitability, debt reduction and growth priorities

Chairman and CFO William Scott discusses Meridian Holdings’ improving financial performance, gaming technology, debt reduction, Brazil exposure and strategic priorities for the next 12 months...

Physitrack CEO Henrik Molin outlines EMR Launch, AI strategy and 2027 growth plans

Physitrack CEO Henrik Molin discusses 14% year-on-year revenue growth, early sign-ups for its new electronic medical record system, remote therapeutic monitoring and plans to expand its AI-powered healthcare technology offering in 2027...

Genflow Biosciences CEO Dr Eric Leire discusses SIRT6 gene therapy results in aged dogs

Genflow Biosciences CEO Dr Eric Leire discusses interim SLAB-VET trial results, the potential of SIRT6 gene therapy in ageing dogs, plasmid DNA delivery, veterinary licensing opportunities and progress across the company's human gene therapy programmes...

Oriole Resources’ Martin Rosser outlines Wapouzé development plans (LON:ORR)

Oriole Resources plc CEO Martin Rosser discusses the maiden 32.2 million tonne resource at Wapouzé in Cameroon, the potential for a multi-decade quarrying operation and plans to secure industry partners...

Hercules CEO Brusk Korkmaz outlines £5m contract wins and £50m growth target

Hercules plc CEO Brusk Korkmaz discusses £5 million of new civil project contracts, opportunities arising from the UK water sector’s £104 billion AMP8 investment programme and plans to grow annual civil projects delivery from £16 million to more than £50 million within five years...

Avingtrans CEO Steve McQuillan on record revenue, nuclear demand and medical imaging progress

Avingtrans plc (LON: AVG) CEO Steve McQuillan discusses record revenue of £163 million, adjusted EBITDA exceeding £20 million, a strong order book and growing demand for nuclear engineering products...

Finsbury Growth & Income Trust: Nick Train on AI, Brands and UK Valuations

Finsbury Growth & Income Trust portfolio manager Nick Train discusses the trust’s long-term investment approach, AI and data businesses, consumer brands, recent holdings including TP ICAP and Games Workshop, and the valuation gap between UK and US-listed companies...

Manx Financial CEO Douglas Grant on record £422.9m loan book and Payment Assist growth

Manx Financial Group CEO Douglas Grant discusses the Group’s first-half 2026 performance, record loan book, Payment Assist growth, Triskel Finance, AI and automation, and plans to expand into Ireland and the UK...

Chesnara reports early acquisition synergies as M&A pipeline remains strong (LON:CSN)

Chesnara says recent acquisitions have delivered £51 million of structural day one synergies, with further benefits expected from migration, integration and capital management. The group also remains positive on its M&A pipeline, while exploring AI-led efficiencies and further opportunities to improve cash generation...

CMC Markets – A catch up with Lord Peter Cruddas

CMC Markets CEO Lord Peter Cruddas said the group is accelerating its expansion across B2B and institutional markets, with more than 300 global partnerships and agreements with Revolut, ASB and Westpac. ASB is expected to launch before the end of 2026, while Westpac remains on track for early 2027...

Biotech Growth Trust Portfolio Manager on valuations, M&A and sector recovery

Biotech Growth Trust Co-Portfolio Manager Josh Golomb discusses the long-term investment opportunity in biotechnology, BIOG’s recent performance, recovering valuations, pharmaceutical M&A activity and developments in cancer treatments...

CMC Markets MD Chris Cheverall on 24/7 market access, CMC Connect and AI opportunities

CMC Markets MD Chris Cheverall discusses rising demand for 24/7 market access, the expansion of CMC Connect, API technology and how AI could create new distribution opportunities across the institutional business...

Premier Miton UK Multi Cap Income Fund: The case for UK income and small-cap stocks

Gervais Williams outlines his views on UK equities, income growth and the potential for a shift towards lower-beta, income-generating shares...

Personal Group praised by Fund Manager for income growth and market share gains

Premier Miton’s Gervais Williams discusses Personal Group Holdings’ 22% rise in adjusted EBITDA, record insurance sales, improving market share and prospective dividend yield of around 6%...
Search

Funds

Q & A

FTSE 100

Funds